PPLI Goes Mainstream: What the $44 Billion Headline Actually Measures

Over the weekend, a structure that has spent three decades being explained one meeting at a time was explained to everybody at once.

The Wall Street Journal ran it under the headline “A Roth IRA on Steroids”: Wealthy Americans Find Another Tax-Free Way to Invest, published on 29 August and reported by Miriam Gottfried, who moved onto the paper’s individual investing and wealth management beat in February. That assignment is itself a small signal: the story was covered as wealth management rather than as a tax-shelter exposé. The phrase in the headline is a quotation. Jim White of Great Oak Wealth Management told the paper it is “a Roth IRA on steroids for people who can afford it and want to leave it to their heirs.” The paper’s own promotional line described ultrawealthy Americans “pouring billions of dollars into a once-quiet corner of the life-insurance industry.” Within hours the story had been summarised in retail personal-finance newsletters whose readers will never write a seven-figure premium cheque. That is the part worth noticing. Private placement life insurance has been covered before, in trade press, in tax journals, in a Senate investigation that produced a week of headlines in February 2024. It has not previously been covered as something a general reader might reasonably want explained.

Two things are now circulating. One is a number: more than $44 billion of assets held inside PPLI policies at the end of 2025. The other is a phrase, “a Roth IRA on steroids,” which is doing more work in the public understanding of this structure than any figure will.

Both deserve scrutiny. Neither is the story.

The $44 Billion Number Is Not the Real Story

Start with what the figure measures, because almost every restatement of it since Saturday has dropped at least one qualifier.

It describes assets under administration inside the policies, not premium paid and not death benefit. It is dated to the end of 2025, eight months before publication. And it comes from a private industry survey. The day after the story ran, Life Insurance Strategies Group confirmed that the figure was its own, drawn from the third edition of the U.S. PPLI Market Report it publishes with Lion Street, and stated it as “more than $44 billion in assets under administration across the largest carriers surveyed at the end of 2025.”

Read that qualifier again, because it did not survive the weekend. “The largest carriers surveyed” means the carriers that agreed to hand over a number. Within a day, secondary coverage had converted it into “the five largest carriers” — a claim about market rank that nobody had made. The figure had been in circulation for less than forty-eight hours and had already acquired a precision it never had.

That last point is not a complaint about the reporting. It is a fact about the market. There is no public series to check the number against, and the reason is documented in the one place that had the power to compel an answer.

When the Senate Finance Committee wanted PPLI data in 2022, it did not consult a regulator or a database. It sent detailed document requests to seven carriers, because the information was not otherwise available. Its February 2024 staff report says the domestic market it examined was incomplete and the offshore market “even more opaque.” The nearest thing the industry has to a voluntary census is the U.S. PPLI Market Report, whose third edition was published on 15 May 2026 by Lion Street with Life Insurance Strategies Group, and which is participation-based: four life insurers and two fund administrators took part. A carrier that declines to participate is simply not in it. That is the dataset behind the $44 billion.

So every public number attached to this market comes from a congressional document request, a survey of carriers willing to answer, or an estimate. None of them is a market statistic in the sense a reader might assume when a newspaper prints one.

Which brings us to the three figures now being strung together as though they were a series.

Year-end 2022. The Senate Finance Committee’s seven carriers held 3,061 domestic PPLI policies. Measured by the assets supporting those policies, the total was $9.45 billion. Measured by death benefit, the same policies came to $39.7 billion. Both numbers are in the same exhibit of the same report, describing the same contracts.

February 2024. The committee’s press release announced an industry “holding at least $40 billion”. That $40 billion is the face amount. It is the aggregate death benefit of the policies, not the money inside them. The report defines the terms carefully and then, in its own executive summary, compresses them: “the PPLI industry is now at least a $40 billion tax shelter.”

Year-end 2025. More than $44 billion of assets under administration across the carriers surveyed for the industry report the Journal drew on.

The $40 billion figure has anchored four years of political coverage of this structure, and it is a death benefit total. The corresponding asset figure, from the same seven carriers on the same date, is roughly a quarter of it. Anyone who has read that $40 billion as “money sheltered” has been reading a life insurance industry’s face amount as though it were an investment balance.

Which leaves exactly one pairing that is even roughly like-for-like: $9.45 billion of assets across seven carriers at the end of 2022, against more than $44 billion across the carriers surveyed at the end of 2025. Even that is not a growth rate. The carrier sets differ. One was compiled under compulsory document request; the other was volunteered to a private survey. Both cover the US domestic market and exclude offshore policies, but the committee reached every carrier it named while the survey reached only those who replied.

The available evidence establishes substantial scale. It does not support a defensible public growth rate, and computing one would be arithmetic performed on incompatible measurements.

One carrier has published its own figure, which is worth reading precisely rather than folding into the aggregate. Axcelus Financial reported in February 2026 that it “surpassed $18 billion in assets under administration, representing a 15% increase from 2024.” That is a company-wide number covering private placement life insurance and annuities, individual and institutional business, across its US and Bermuda operations. It is not a PPLI-only, US-only figure, so it cannot be divided into the survey total to produce a market share. What it does give is the one carrier-level growth rate in this market that comes from the carrier itself, on a stated basis, with its scope on the record.

There is one further number worth keeping in view, and its units matter. The Senate report found that PPLI represents about 0.003 percent of individual life insurance policies in force in the United States, counted by policy. That is a statement about how few contracts there are, not about how little money is involved. Roughly three thousand Americans held the policies the committee examined, with an average death benefit near $13 million. A very small number of contracts can carry a very large pool of assets. Negligible by count, material by value, held by a group small enough to fit in a mid-sized concert hall: that combination is most of what makes this market politically legible.

Scale is not what changed last weekend.

Why PPLI Is Entering the Conversation Now

Visibility of this kind usually has several causes and no single one. What follows are conditions that made the structure more discussable in 2026 than it was in 2019. They are not a causal chain, and nobody can currently demonstrate which of them is doing the work.

Portfolios got harder to hold tax-efficiently. The allocation shift toward private markets is well documented; its tax consequence is discussed less. The strategies differ from one another more than the category label suggests. Private credit produces current interest income taxed at ordinary rates. Hedge fund tax character varies materially with strategy, instruments, turnover and holding period. Private equity returns often arrive as long-term capital gain, realised episodically rather than annually. What matters for an insurance wrapper is not the label but the timing and character of what a portfolio actually recognises each year, and a portfolio weighted toward income-heavy or high-turnover strategies can carry materially more annual drag than a low-turnover equity portfolio. That difference is what makes the arithmetic worth running, and it is why coverage of PPLI so often arrives attached to coverage of private markets. Our analysis of what actually sits inside these policies covers the mechanics.

Wealth became more mobile. A trust is a creature of a particular legal system. A life insurance contract may offer portability advantages in some cross-border fact patterns, depending on the policyholder’s residence, the policy’s jurisdiction, ownership, beneficiary residence and local recognition of the contract. None of that is general, and it is the point most often flattened into a rule in coverage of this subject. It matters to a growing population of families whose members hold different tax residences from one another.

Family offices started modelling rather than being pitched. A single-family office with an investment committee and a CIO evaluates a wrapper the way it evaluates a fund: net of everything, against a stated benchmark, with a break-even. That is a harder sale and a better filter. It also produces a different kind of demand, one that asks for the cost table before the brochure.

Legislation put the acronym in print months ago. Senator Ron Wyden, the Finance Committee’s ranking member, introduced the Protecting Proper Life Insurance from Abuse Act on 13 April 2026 as S. 4279. It was read twice and referred to the Committee on Finance, and there has been no further action since. It has no cosponsors and no House companion. It is proposed legislation, not law, and should not be planned around as though it were. But it did put “private placement life insurance” into tax-policy news four months before the Journal’s story, which is how an acronym gets primed for a general audience. Our analysis of what S. 4279 would and would not do sets out the 25-contract test and the proposed §7702C mechanism.

Adviser understanding improved, from a low base. This is the condition with the most direct evidence behind it, and the evidence comes from outside the United States.

What is absent from the public record is any documented demand shock. Nothing we have found suggests that a wave of families independently decided in 2025 that they wanted insurance-based structuring. The sequence visible in the data runs the other way: the structure became easier to explain before it became more widely used.

This Is Not Only an American Story

Here the discipline has to be strict, because the numbers available for the rest of the world measure something different from the Journal’s, and the temptation to add them together is obvious.

The second global market study conducted by NMG Consulting for Utmost, published in early August 2026, found that international wealth insurance new business sales rose from £36.4 billion in 2023 to £53.0 billion in 2025, a 46% increase over two years and a compound rate of about 21% (International Adviser, 4 August 2026). The study projects roughly £87 billion by the end of the decade and puts penetration at about 1% of the £49 trillion of high-net-worth investible assets held outside the United States. It was commissioned by a provider in the market it measures, which is worth knowing without being disqualifying.

Every element of that is incompatible with the $44 billion figure:

• It is annual sales, a flow. The Journal’s figure is accumulated assets, a stock.
• It excludes the United States entirely. The Journal’s figure is American.
• It covers the whole international wealth-insurance category, which includes unit-linked wealth-planning contracts and variable universal life that are not private placement life insurance in the US sense.
• It is denominated in sterling.

Two numbers of similar visual magnitude, describing different quantities, in different currencies, for different products, in different markets. They cannot be added, averaged or read as corroboration of one another. Any article that implies otherwise is manufacturing a global market that has not been measured.

What the international data does supply is a more interesting finding, and it is behavioural.

Asia. Sales rose from £5.7 billion in 2023 to £6.4 billion in 2025, with Hong Kong and Singapore leading the segment and private banks increasingly routing business through international brokers (International Adviser, 25 August 2026; Asia Insurance Review, 26 August 2026). Mark Christal, Utmost’s head of Asia, attributes the change to “greater understanding among brokers and advisers,” which he says “is now beginning to drive up adoption among a wider segment.”

Middle East. Sales rose from £2.4 billion to £3.0 billion over the same period, with Derek Gemmell, Utmost’s head of Middle East and Africa, pointing to an expanding high-net-worth population in the region. Middle East Insurance Review reported the prior-year equivalent in July 2025, when the regional total stood at about £2.1 billion.

Europe. The evidence is practitioner testimony rather than a published series, and should be weighted accordingly, but it is consistent: senior European intermediaries have spent 2026 describing high-net-worth insurance as moving out of a specialist niche.

The United States. There is no equivalent independently published series, for the reasons set out above. The asymmetry deserves stating: the market that generated this week’s headline is the one with the least public data.

The regions differ, and the drivers named in each are plural: growth in high-net-worth populations, cross-border mobility, private-bank distribution, changing family structures. But one thread recurs across them, and it is not client demand. In Asia the growth is attributed to intermediaries understanding the product. In the Middle East it is attributed to distribution reaching a wider client base. The same study reports UK advisers under capacity strain as demand grows. If professional understanding is a recurring constraint on adoption internationally, a burst of client-side awareness in the market with the thinnest professional preparation is a predictable source of friction.

Is PPLI Really a “Roth IRA on Steroids”?

The phrase is doing enormous work, and it deserves to be taken seriously rather than dismissed, because it is nearly right in a way that makes its failures more consequential than an obviously wrong analogy would be.

What it gets right: both structures can allow investment returns to compound without an annual tax event, and both can deliver value without income tax at the end. For a reader meeting the concept for the first time, that is a useful handhold. It explains, in five words, why anyone would bother.

What it obscures is most of what determines whether the structure works.

The constraint is on a different thing. A Roth IRA limits how much can go in: it requires earned compensation, caps the annual contribution, and phases out direct contributions above certain income levels. PPLI has no contribution cap, but it constrains what the arrangement must be. To receive the tax treatment, the contract has to qualify as life insurance under IRC §7702, which requires death benefit in a defined relationship to cash value. You are not buying an uncapped Roth. You are buying a life insurance contract, subject to underwriting, whose insurance cost you may not want, in order to obtain a wrapper you do.

The compliance obligation continues for the life of the contract. Retirement accounts have their own investment-side rules, and self-directed ones can run into prohibited-transaction problems. But PPLI layers a distinct and continuing framework over the assets supporting the policy: the investor control doctrine, which limits the policyholder’s involvement in investment decisions, and IRC §817(h), which imposes diversification requirements on the segregated account. A policyholder who exercises sufficient control over the underlying investments risks being treated as their owner and taxed on their income directly. The doctrine runs from a line of revenue rulings, including Rev. Rul. 2003-91, through Webber v. Commissioner, 144 T.C. 324 (2015), where the Tax Court applied it against the taxpayer. Our treatment of the rules governing policyholder control covers what a policyholder may and may not do.

“Tax-free” describes different things at different moments. During the life of a compliant policy, investment returns accumulate without current income tax. That is deferral, and deferral is where most of the economic value is created. The genuinely tax-free element is the death benefit, which is generally received free of income tax under IRC §101(a), subject to exceptions such as the transfer-for-value rule. Lifetime access is a third thing again: withdrawals up to basis and policy loans can be taken without current income tax while a policy is in force and is not a modified endowment contract, which depends on how quickly it was funded and is governed by the seven-pay test under IRC §7702A. A surrender is taxable on the gain. A Roth’s qualified distributions are tax-free to the owner on far simpler terms.

PPLI has an insurance cost stack, and therefore a break-even. Every account has costs: funds, advice, custody, trading. What distinguishes PPLI is a structural layer that a Roth does not have at all, in premium loads, state premium tax, cost of insurance and annual asset-based charges, and it is large enough that economic break-even sits at the centre of the suitability question rather than at its edges. There is a level of portfolio tax-inefficiency below which the wrapper destroys value, and a horizon below which it never earns its costs back. The economics and break-even analysis is where that gets settled, portfolio by portfolio.

The deeper problem with “on steroids” is the implication of more of the same thing. It suggests a Roth IRA with the cap lifted. What PPLI is, is a different instrument with a different profile of ways to fail. A retirement account’s principal risks sit at the entry gate and in a defined set of prohibited transactions. A life insurance contract has to keep qualifying, as insurance, as a diversified account, as something the policyholder does not effectively manage, for as long as it is held. A family that internalises the first analogy will be unprepared for the second.

If a reader takes one thing from the phrase, it should be this: the tax treatment is not the hard part. It is statutory, litigated and reasonably well settled. The hard part is the discipline required to keep it and the arithmetic required to justify paying for it. For the mechanics themselves, our guide to private placement life insurance is the starting point.

What the Headlines Leave Out

A story with a limited word count and a general audience has to choose. Here is what got cut, in rough order of how often it is the reason a family concludes that PPLI is not for them.

The economics are not automatic. The wrapper’s value is the tax drag it removes, less everything it costs. A portfolio of low-turnover index equity produces little annual taxable income, so there is little drag to remove and the charges land on top of a benefit that barely exists. The structure earns its keep on portfolios that are heavily taxed year by year. It can be value-destroying on portfolios that are not.

The control limitation is real. Not a formality and not a disclosure item. The policyholder does not select individual investments inside the policy, does not instruct trades, and cannot treat the account as a brokerage account with a tax feature. Families who cannot accept that should not proceed, and the better practitioners say so early.

Carrier and jurisdiction quality vary more than ratings suggest. A financial strength rating measures a carrier’s ability to pay claims. It says nothing about the insulation of separate-account assets, the quality of custody, or a regulator’s record. Those are separate enquiries, covered in our carrier due diligence framework and our comparison of PPLI domiciles.

Liquidity is constrained by design. Surrender charges, surrender periods, and the fact that the most tax-efficient exit is the one nobody schedules. Capital that may be needed within a decade often fails this test whatever its tax profile.

Legislative risk is live, and should be stated accurately. S. 4279 exists, has been referred to committee, has no cosponsors and no House companion, and has not moved since April. Treasury projected roughly $6.9 billion over ten years for a similar proposal; independent estimates of the Wyden bill range from $1 billion to $10 billion (Bloomberg Tax, 8 May 2026). A band that wide is what uncertainty looks like when nobody knows how many policies would restructure rather than pay.

Suitability is narrower than the coverage implies. An article about a structure held by roughly three thousand American families will be read by a great many more than three thousand people. Our assessment of who PPLI may suit, and who it may not is deliberately written from the second half of that sentence.

What This Means for Wealthy Families

The useful response to a story like this is not to decide whether PPLI is good. It is to work out whether the conditions that make it work are present in a particular portfolio. Six questions, in the order they are worth asking.

How much tax drag does this portfolio actually generate? Not in principle. In dollars, this year. Everything downstream depends on that number, and it is often the one nobody has calculated before the structure is discussed. Our portfolio tax drag calculator does the arithmetic.

Which holdings produce it? Drag is rarely spread evenly, and is often concentrated in a small number of positions, which makes the real question one about a sleeve rather than the whole portfolio. The hedge fund tax x-ray and the private credit real yield model are built for that.

What is the horizon, and does the money need to come back? Deferral is worth what compounding makes it worth, and compounding needs time.

Where does break-even sit, after everything? After premium loads, asset charges and cost of insurance, and after the tax that would fall due on a surrender. Two break-evens, not one. Our PPLI break-even model reports both.

Which tax regime applies, to which person? A US taxpayer, a non-US person, and a family whose members hold different residences face materially different analyses, and treatment varies by jurisdiction in ways no general-audience article distinguishes. Our work on PPLI for non-US persons is the starting point for the second and third cases.

Does the existing structure change the answer? An irrevocable trust already in place, a completed estate freeze, or a family limited partnership can each change whether a wrapper adds anything, and who should own it.

The honest outcome of this exercise is frequently that the structure is not warranted. That is not a failure of the analysis. It is the analysis working.

The question raised by mainstream coverage is not whether PPLI is tax-advantaged. It is whether the tax drag removed from one particular portfolio exceeds what the structure costs to run, for long enough to matter.

What This Means for Advisers

Mainstream coverage does not change what PPLI is. It changes the sequence in which an adviser meets it.

Until this week, the usual order was that an adviser learned about the structure, formed a view, and raised it with a client for whom it might fit. That order can now invert. A client arrives holding a term they read at the weekend and asks a question that cannot be deferred at no cost. “Let me look into it” is an honest answer that still concedes something, because the client will look into it too, and what they find will not have been chosen for them.

The international evidence suggests professional understanding is one of the binding constraints on this category. Utmost’s Asia head attributes rising adoption to improved understanding among brokers and advisers; the same study reports UK advisers under capacity strain. A burst of client-side awareness in the market with the least public data and the thinnest formal training is a predictable place for that constraint to bite.

There is a specific gap behind it. Our review as of August 2026 did not identify a standing accredited curriculum in private placement life insurance. Where the subject is taught for credit at all, it appears as individual sessions inside broader programmes, such as conference sessions within the AICPA and CIMA programme and estate-planning institutes registered with NASBA’s National Registry. The industry’s own dedicated PPLI conference lists no continuing-education credit at all. That is a first-party finding from our own search rather than an audit of every provider’s catalogue, and it may be incomplete. It is nonetheless a strange position for a structure that has attracted a Senate investigation, a bill and a Wall Street Journal feature.

Two practical responses, neither of which requires committing to anything.

Run one real client file through the arithmetic before the conversation happens rather than during it. The tax-alpha simulator is open, requires no account, and models charges against drag year by year with an explicit break-even. Working through a single portfolio you actually know is worth more than reading three explainers.

Then decide what a good “no” sounds like in your practice, because many of these conversations should end in one. The PPLI.com Advisor Workspace collects the case work, the due diligence frameworks and the fact patterns where a wrapper is the wrong instrument.

Where the PPLI Conversation Goes Next

An acronym that reaches general financial vocabulary tends to stay there, and it gets asked about badly for a while before it gets asked about well.

The likely consequence is a widening gap between awareness and suitability. Interest can rise faster than the number of families for whom the structure is appropriate, which worsens the ratio of enquiries to sensible cases, which makes the quality of the filter the thing that matters. That filter is not a sales process. It is arithmetic, applied early, by someone with no stake in the answer.

Two things are worth watching through the remainder of 2026. Whether S. 4279 moves at all, which will say more about the political appetite for this fight than the bill’s text does. And whether the next edition of the Utmost and NMG study, or any comparable American work, produces a US series that can be checked. The most striking feature of this week’s reporting is that the largest market for this structure is the one with no published data, and that a newspaper had to source a figure no regulator collects.

For most of the past decade the question in this market was “what is PPLI?” That question has now been answered for a very large audience, in five words, by a metaphor that is only partly true.

The question that follows is harder and considerably more useful: when does it work, for whom, under which structure, and at what cost. PPLI.com exists to answer that one.

Sources and Authorities

Figures in this article are attributed to their originating documents wherever one exists. Where a figure has been reported without a disclosed methodology, this article says so rather than repeating it as established data. The observation about accredited education is PPLI.com’s own review as of August 2026 and is labelled as such in the text. Our editorial standards set out how we handle corrections.

• Miriam Gottfried, The Wall Street Journal, “A Roth IRA on Steroids”: Wealthy Americans Find Another Tax-Free Way to Invest, 29 August 2026
• Life Insurance Strategies Group, LISG PPLI Market Research Cited in The Wall Street Journal, 30 August 2026
• US Senate Committee on Finance, Private Placement Life Insurance: A Tax Shelter for the Ultra-Wealthy Masquerading as Insurance, majority staff report, 21 February 2024
• US Senate Committee on Finance, New Wyden Bill Would Close Private Placement Life Insurance Tax Shelter, 13 April 2026
• S. 4279, 119th Congress, PPLI Abuse Act, introduced 13 April 2026
• Axcelus Financial, 2025 financial results, 25 February 2026
• Lion Street and Life Insurance Strategies Group, Third Edition of the U.S. PPLI Market Report, 15 May 2026
• Joshua Becker and Robert Amoruso, Bloomberg Tax, Growth of Wealth-Driven Life Insurance Demands Adviser Scrutiny, 8 May 2026
• International Adviser, International wealth insurance sales surge 46% to hit £53bn, 4 August 2026, and Sales of international wealth insurance in Asia and the Middle East reach almost £10bn, 25 August 2026
• Asia Insurance Review, Demand for international wealth insurance rising in Asia, 26 August 2026
• Insurance Business UK, Adviser capacity strains as wealth insurance demand grows, 5 August 2026
• Hubbis, Serge Hediger, Beyond PPLI: HNW Insurance Comes of Age in Europe, 14 July 2026
• 26 U.S.C. §7702, §7702A, §817(h), §101
• Internal Revenue Service, Rev. Rul. 2003-91; Webber v. Commissioner, 144 T.C. 324 (2015)

Statutory references in this article are to United States federal law. Treatment of insurance contracts varies materially by jurisdiction and by the residence of the policyholder and beneficiaries. S. 4279 is proposed legislation and is not law. Tax outcomes depend on policy design, funding and continuing compliance, and are not guaranteed. Nothing here is individualised legal, tax, investment or insurance advice. Published 31 August 2026; last reviewed 31 August 2026. Updated 31 August 2026 to attribute the $44 billion figure to its now-disclosed source and to correct the carrier description from “the five largest carriers” to “the largest carriers surveyed”.

PPLI.com is an independent research and education platform. It does not sell insurance, manage assets or represent a carrier. Families and family offices weighing whether an insurance structure earns its place in a specific portfolio can request a confidential review, including the cases where the answer is no.